About Index Trending news
Analyze
Top 50 Pricing
LPATH

LPATH

LPATH

Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
$12,527,521
Post-IPO equity
$12,500,000
Employees

Team size

10+
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when LPATH makes some noise.